Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

January 31, 2012

Conditions
Sarcoma
Interventions
DRUG

paclitaxel

Trial Locations (23)

13385

CHU de la Timone, Marseille

14076

Centre Regional Francois Baclesse, Caen

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

25030

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon

31052

Institut Claudius Regaud, Toulouse

33076

Institut Bergonie, Bordeaux

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

35042

Centre Eugene Marquis, Rennes

37044

Centre Hospitalier Universitaire Bretonneau de Tours, Tours

42270

Institut de Cancerologie de la Loire, Saint-Priest-en-Jarez

44805

Centre Regional Rene Gauducheau, Nantes-Saint Herblain

49036

Centre Paul Papin, Angers

59020

Centre Oscar Lambret, Lille

63011

Centre Jean Perrin, Clermont-Ferrand

69373

Centre Leon Berard, Lyon

69437

Hopital Edouard Herriot - Lyon, Lyon

75248

Institut Curie Hopital, Paris

75674

Hopital Cochin, Paris

76031

Hopital Charles Nicolle, Rouen

76038

Centre Henri Becquerel, Rouen

92211

Centre Rene Huguenin, Saint-Cloud

06189

Centre Antoine Lacassagne, Nice

F-94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

UNICANCER

OTHER

NCT00217607 - Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter